| Validation of chronic obstructive pulmonary disease recording in the Clinical Practice Research Datalink (CPRD-GOLD) JK Quint, H Müllerova, RL DiSantostefano, H Forbes, S Eaton, JR Hurst, ... BMJ open 4 (7), e005540, 2014 | 250 | 2014 |
| Improved bronchodilation with levalbuterol compared with racemic albuterol in patients with asthma HS Nelson, G Bensch, WW Pleskow, R DiSantostefano, S DeGraw, ... Journal of allergy and clinical immunology 102 (6), 943-952, 1998 | 235 | 1998 |
| Reporting formative qualitative research to support the development of quantitative preference study protocols and corresponding survey instruments: guidelines for authors and … IL Hollin, BM Craig, J Coast, K Beusterien, C Vass, R DiSantostefano, ... The Patient-Patient-Centered Outcomes Research 13, 121-136, 2020 | 141 | 2020 |
| Relationship between blood eosinophils and clinical characteristics in a cross-sectional study of a US population-based COPD cohort RL DiSantostefano, D Hinds, H Van Le, NC Barnes Respiratory medicine 112, 88-96, 2016 | 86 | 2016 |
| Risk of pneumonia with inhaled corticosteroid versus long-acting bronchodilator regimens in chronic obstructive pulmonary disease: a new-user cohort study RL DiSantostefano, T Sampson, HV Le, D Hinds, KJ Davis, ND Bakerly PLoS One 9 (5), e97149, 2014 | 64 | 2014 |
| Is Johnny wheezing? Parent–child agreement in the childhood asthma in America survey KJ Davis, R Disantostefano, DB Peden Pediatric Allergy and Immunology 22 (1‐Part‐I), 31-35, 2011 | 62 | 2011 |
| An evaluation of the economic costs and patient‐related consequences of treatments for benign prostatic hyperplasia RL Disantostefano, AK Biddle, JP Lavelle BJU international 97 (5), 1007-1016, 2006 | 62 | 2006 |
| Gay Identification and Psychological Health in HIV‐Positive and HIV‐Negative Gay Men1 J Leserman, R DiSantostefano, DO Perkins, DL Evans Journal of Applied Social Psychology 24 (24), 2193-2208, 1994 | 58 | 1994 |
| Identification of responders to inhaled corticosteroids in a chronic obstructive pulmonary disease population using cluster analysis DR Hinds, RL DiSantostefano, HV Le, S Pascoe BMJ open 6 (6), e010099, 2016 | 56 | 2016 |
| The long-term cost effectiveness of treatments for benign prostatic hyperplasia RL DiSantostefano, AK Biddle, JP Lavelle Pharmacoeconomics 24, 171-191, 2006 | 53 | 2006 |
| Risk of pneumonia with inhaled corticosteroid/long-acting β2 agonist therapy in chronic obstructive pulmonary disease: a cluster analysis RL DiSantostefano, H Li, D Hinds, DV Galkin, DB Rubin International journal of chronic obstructive pulmonary disease, 457-468, 2014 | 38 | 2014 |
| Which patients with chronic obstructive pulmonary disease benefit from the addition of an inhaled corticosteroid to their bronchodilator? A cluster analysis RL DiSantostefano, H Li, DB Rubin, DA Stempel BMJ open 3 (4), e001838, 2013 | 35 | 2013 |
| Appraising patient preference methods for decision-making in the medical product lifecycle: an empirical comparison C Whichello, B Levitan, J Juhaeri, V Patadia, R DiSantostefano, CA Pinto, ... BMC medical informatics and decision making 20, 1-15, 2020 | 34 | 2020 |
| Longitudinal study of social support and social conflict as predictors of depression and dysphoria among HIV‐positive and HTV‐negative gay men J Leserman, R Disantostefano, DO Perkins, C Murphy, RN Golden, ... Depression 2 (4), 189-199, 1994 | 33 | 1994 |
| Special applications of pharmacoepidemiology following individuals contributed to writing sections of this chapter:, D Lee, ... Textbook of pharmacoepidemiology, 337-406, 2013 | 21 | 2013 |
| Changes in asthma insights and reality in Japan (AIRJ) in 2005 since 2000 M Adachi, K Ohta, A Morikawa, S Nishima, S Tokunaga, ... Arerugi=[Allergy] 57 (2), 107-120, 2008 | 21 | 2008 |
| Ecologic analysis of asthma-related events and dispensing of inhaled corticosteroid-and salmeterol-containing products RL DiSantostefano, KJ Davis, S Yancey, C Crim Annals of Allergy, Asthma & Immunology 100 (6), 558-565, 2008 | 19 | 2008 |
| Chronic respiratory disease, comorbid cardiovascular disease and mortality in a representative adult US cohort DM Mannino, KJ Davis, RL DiSantostefano Respirology 18 (7), 1083-1088, 2013 | 16 | 2013 |
| Quantitative benefit–risk assessment: state of the practice within industry MY Smith, J van Til, RL DiSantostefano, AB Hauber, K Marsh Therapeutic Innovation & Regulatory Science 55, 415-425, 2021 | 15 | 2021 |
| Something is better than nothing: the value of active intervention in stated preferences for treatments to delay onset of Alzheimer's disease symptoms FR Johnson, RL DiSantostefano, JC Yang, SD Reed, J Streffer, B Levitan Value in Health 22 (9), 1063-1069, 2019 | 15 | 2019 |
Gwenda SimonsUniversity of Birmingham, Insitute of Inflammation and AgeingVerified email at bham.ac.uk
